David F. Schneider, MD, MS Print Friendly Page
Dr. Schneider is certified by the American Board of Surgery, and he is a member of multiple specialty societies including the American Association of Endocrine Surgeons, the American Thyroid Association, the North American NeuroEndocrine Tumor Society, and the American Association of Clinical Endocrinologists. He specializes in endocrine surgery, treating diseases of the thyroid, parathyroid, and adrenal glands. He utilizes several minimally invasive techniques to treat endocrine disorders (endoscopic thyroidectomy, minimally invasive parathyroidectomy, laparoscopic adrenalectomy, focused exploration for recurrent thyroid cancer).
UW Health Clinics
Regional Specialty Clinics
UW School of Medicine and Public Health
|Department of Surgery|
Professional Certifications and Education
Endocrine Surgery, University of Wisconsin Hospital and Clinics
Loyola University Medical Center, Maywood, IL
Loyola University Chicago Stritch School of Medicine, Maywood, IL, 2004
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Dr. Schneider conducts outcomes research in conjunction with the Wisconsin Surgical Outcomes Program (WiSOR). His research program investigates the optimization of cancer care in the United States with a particular interest in endocrine cancers. This work utilizes large national databases which can impact national healthcare and policy initiatives. He also conducts clinical research working on hyperparathyroidism, thyroid cancer, Graves' Disease, and adrenal disorders.
Elfenbein DM Schneider DF Havlena J Chen H Sippel RS .
Clinical and socioeconomic factors influence treatment decisions in Graves' disease. Ann Surg Oncol. 2015 Apr;22(4):1196-9
[PubMed ID: 25245130]
Elfenbein DM Weber S Schneider DF Sippel RS Chen H .
CaPTHUS scoring model in primary hyperparathyroidism: can it eliminate the need for ioPTH testing? Ann Surg Oncol. 2015 Apr;22(4):1191-5
[PubMed ID: 25212837]
Ayers RR Tobin K Sippel RS Balentine C Elfenbein D Chen H Schneider DF .
Does levothyroxine administration impact parathyroid localization? J Surg Res. 2015 Mar 31;
[PubMed ID: 25917998]
Sohn JA Oltmann SC Schneider DF Sippel RS Chen H Elfenbein DM .
Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate? Am J Surg. 2015 Mar;209(3):483-7
[PubMed ID: 25556028]
Rajaei MH Oltmann SC Schneider DF Sippel RS Chen H .
Outcomes after subtotal parathyroidectomy for primary hyperparathyroidism due to hyperplasia: significance of whole vs. partial gland remnant. Ann Surg Oncol. 2015 Mar;22(3):966-71
[PubMed ID: 25245126]
Oltmann SC Brekke AV Schneider DF Schaefer SC Chen H Sippel RS .
Preventing postoperative hypocalcemia in patients with Graves disease: a prospective study. Ann Surg Oncol. 2015 Mar;22(3):952-8
[PubMed ID: 25212835]
Oltmann SC Schneider DF Chen H Sippel RS .
All thyroid ultrasound evaluations are not equal: sonographers specialized in thyroid cancer correctly label clinical N0 disease in well differentiated thyroid cancer. Ann Surg Oncol. 2015 Feb;22(2):422-8
[PubMed ID: 25234019]
Rajaei MH Bentz AM Schneider DF Sippel RS Chen H Oltmann SC .
Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) Over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism. Ann Surg Oncol. 2015 Feb;22(2):454-9
[PubMed ID: 25192677]
Schneider DF Elfenbein D Lloyd RV Chen H Sippel RS .
Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer. Ann Surg Oncol. 2015 Jan;22(1):158-63
[PubMed ID: 25092163]
Schneider DF Sonderman PE Jones MF Ojomo KA Chen H Jaume JC Elson DF Perlman SB Sippel RS .
Failure of radioactive iodine in the treatment of hyperthyroidism. Ann Surg Oncol. 2014 Dec;21(13):4174-80
[PubMed ID: 25001092]
Hsu KT Sippel RS Chen H Schneider DF .
Is central lymph node dissection necessary for parathyroid carcinoma? Surgery. 2014 Dec;156(6):1336-41; discussion 1341
[PubMed ID: 25456903]
Somnay YR Weinlander E Schneider DF Sippel RS Chen H .
The effect of cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomy. Surgery. 2014 Dec;156(6):1308-13; discussion 1313-4
[PubMed ID: 25456900]
Oltmann SC Brekke AV Macatangay JD Schneider DF Chen H Sippel RS .
Surgeon and staff radiation exposure during radioguided parathyroidectomy at a high-volume institution. Ann Surg Oncol. 2014 Nov;21(12):3853-8
[PubMed ID: 24866439]
Schneider DF .
Embracing national cancer registries for improved care of rare tumors. Ann Surg Oncol. 2014 Oct;21(11):3375-6
[PubMed ID: 25063007]
Applewhite MK Schneider DF .
Mild primary hyperparathyroidism: a literature review. Oncologist. 2014 Sep;19(9):919-29
[PubMed ID: 25063228]
Schneider DF Mazeh H Oltmann SC Chen H Sippel RS .
Novel thyroidectomy difficulty scale correlates with operative times. World J Surg. 2014 Aug;38(8):1984-9
[PubMed ID: 24615607]
Schneider DF Nookala R Jaraczewski TJ Chen H Solorzano CC Sippel RS .
Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism. Ann Surg Oncol. 2014 Jul;21(7):2303-9
[PubMed ID: 24522995]
Oltmann SC Rajaei MH Sippel RS Chen H Schneider DF .
Primary hyperparathyroidism across the ages: presentation and outcomes. J Surg Res. 2014 Jul;190(1):185-90
[PubMed ID: 24801542]
Mok VM Oltmann SC Chen H Sippel RS Schneider DF .
Identifying predictors of a difficult thyroidectomy. J Surg Res. 2014 Jul;190(1):157-63
[PubMed ID: 24750986]
Elfenbein DM Schneider DF Chen H Sippel RS .
Surgical site infection after thyroidectomy: a rare but significant complication. J Surg Res. 2014 Jul;190(1):170-6
[PubMed ID: 24739508]